Michael Thomas Heffernan Insider Trading $SYBX SYNLOGIC, INC.
Get free email notifications about insider trading for Michael Thomas Heffernan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Thomas Heffernan. Michael Thomas Heffernan is Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Director in Ocata Therapeutics, Inc. ($ACTC) and Director in CORNERSTONE THERAPEUTICS INC ($CRTX) and Chairman, President and CEO in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA) and Director in SYNLOGIC, INC. ($SYBX) and Director in Trevi Therapeutics, Inc. ($TRVI) and in Biohaven Pharmaceutical Holding Co Ltd. ($BHVN).
Michael Thomas Heffernan in SYNLOGIC, INC.
Trading Symbol: SYBXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Thomas Heffernan: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 09 2020
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael Thomas Heffernan in SYNLOGIC, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, BHVN, COLL, CRTX, KERX, ACTC, SYBX, TRVI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 09 2020 | SYBX | SYNLOGIC, INC. | Heffernan Michael Thomas | Director | Option Exercise | A | 2.29 | 30,000 | 68,700 | 30,000 |
Page: 1